Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
53
CME Quote, Financials, Valuation and Earnings
Last price:
$276.27
Seasonality move
:
4.85%
Day range:
$274.99 - $277.00
52-week range:
$224.62 - $290.79
Dividend yield:
1.81%
P/E ratio:
26.79x
P/S ratio:
15.56x
P/B ratio:
3.54x
Volume:
580K
Avg. volume:
2M
1-year change:
15.41%
Market cap:
$99.7B
Revenue:
$6.1B
EPS (TTM):
$10.32
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.9B | $4.7B | $5B | $5.6B | $6.1B | |
| Revenue Growth (YoY) | 0.07% | -3.97% | 7.03% | 11.15% | 9.88% | |
| Cost of Revenues | $1.1B | $966.6M | $1B | $1B | $1.1B | |
| Gross Profit | $3.8B | $3.7B | $4B | $4.5B | $5B | |
| Gross Profit Margin | 77.49% | 79.39% | 79.91% | 81.39% | 82.37% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $250.9M | $895.3M | $637.1M | $877.3M | $770.8M | |
| Operating Expenses | $1.1B | $1.1B | $994.9M | $1.1B | $1.1B | |
| Operating Income | $2.6B | $2.6B | $3B | $3.4B | $3.9B | |
| Net Interest Expenses | $168.9M | $166.9M | $162.7M | $159.4M | $160.9M | |
| EBT. Incl. Unusual Items | $2.7B | $3.4B | $3.5B | $4.2B | $4.5B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $615.7M | $736.7M | $799.3M | $927.4M | $1B | |
| Net Income to Company | $2.1B | $2.6B | $2.7B | $3.2B | $3.5B | |
| Minority Interest in Earnings | $1.2M | $500K | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $2.1B | $2.6B | $2.7B | $3.2B | $3.5B | |
| Basic EPS (Cont. Ops) | $5.88 | $7.30 | $7.41 | $8.87 | $9.69 | |
| Diluted EPS (Cont. Ops) | $5.87 | $7.29 | $7.40 | $8.86 | $9.67 | |
| Weighted Average Basic Share | $357.8M | $358.3M | $358.7M | $359M | $359.4M | |
| Weighted Average Diluted Share | $358.5M | $358.9M | $359.2M | $359.5M | $359.9M | |
| EBITDA | $3.1B | $3B | $3.4B | $3.8B | $4.3B | |
| EBIT | $2.6B | $2.6B | $3B | $3.4B | $3.9B | |
| Revenue (Reported) | $4.9B | $4.7B | $5B | $5.6B | $6.1B | |
| Operating Income (Reported) | $2.6B | $2.6B | $3B | $3.4B | $3.9B | |
| Operating Income (Adjusted) | $2.6B | $2.6B | $3B | $3.4B | $3.9B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.2B | $1.3B | $1.6B | $1.5B | |
| Revenue Growth (YoY) | 2.7% | 10.62% | 8.96% | 18.43% | -2.95% | |
| Cost of Revenues | $248.3M | $255.5M | $255.6M | $279.1M | $272.3M | |
| Gross Profit | $861.6M | $972.3M | $1.1B | $1.3B | $1.3B | |
| Gross Profit Margin | 77.63% | 79.19% | 80.89% | 82.39% | 82.29% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $524M | $181.6M | $193.7M | $192.9M | -- | |
| Operating Expenses | $247.9M | $233.5M | $262M | $281.1M | $292.7M | |
| Operating Income | $613.7M | $738.8M | $820.2M | $1B | $972.6M | |
| Net Interest Expenses | $41.8M | $40.4M | $39.6M | $40.2M | $44M | |
| EBT. Incl. Unusual Items | $1.1B | $880M | $974.3M | $1.2B | $1.2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $169.6M | $200.4M | $224.1M | $264.1M | $269M | |
| Net Income to Company | $926.3M | $679.6M | $750.2M | $912.8M | $908M | |
| Minority Interest in Earnings | -$200K | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $926.3M | $675.7M | $745.8M | $906.6M | $902.3M | |
| Basic EPS (Cont. Ops) | $2.59 | $1.87 | $2.06 | $2.51 | $2.49 | |
| Diluted EPS (Cont. Ops) | $2.58 | $1.87 | $2.06 | $2.50 | $2.49 | |
| Weighted Average Basic Share | $358.4M | $358.7M | $359M | $359.4M | $359.7M | |
| Weighted Average Diluted Share | $359M | $359.3M | $359.6M | $360M | $360.4M | |
| EBITDA | $709.9M | $828.8M | $908.5M | $1.1B | $1.1B | |
| EBIT | $613.7M | $738.8M | $820.2M | $1B | $972.6M | |
| Revenue (Reported) | $1.1B | $1.2B | $1.3B | $1.6B | $1.5B | |
| Operating Income (Reported) | $613.7M | $738.8M | $820.2M | $1B | $972.6M | |
| Operating Income (Adjusted) | $613.7M | $738.8M | $820.2M | $1B | $972.6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $4.6B | $5B | $5.3B | $6B | $6.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1B | $990.1M | $1B | $1.1B | $1.1B | |
| Gross Profit | $3.6B | $4B | $4.3B | $5B | $5.3B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $747.5M | $647.7M | $893.7M | $763.1M | -- | |
| Operating Expenses | $1.1B | $989.5M | $1.1B | $1.1B | $1.1B | |
| Operating Income | $2.5B | $3B | $3.2B | $3.8B | $4.2B | |
| Net Interest Expenses | $166.7M | $164.7M | $159.6M | $159.9M | $170.4M | |
| EBT. Incl. Unusual Items | $3.1B | $3.5B | $4B | $4.5B | $4.8B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $672.8M | $784M | $925.4M | $985M | $1.1B | |
| Net Income to Company | $2.4B | $2.7B | $3B | $3.5B | $3.8B | |
| Minority Interest in Earnings | $1.3M | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $2.4B | $2.7B | $3.1B | $3.5B | $3.8B | |
| Basic EPS (Cont. Ops) | $6.80 | $7.39 | $8.39 | $9.52 | $10.33 | |
| Diluted EPS (Cont. Ops) | $6.79 | $7.35 | $8.38 | $9.51 | $10.32 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $2.9B | $3.3B | $3.6B | $4.2B | $4.5B | |
| EBIT | $2.5B | $3B | $3.2B | $3.8B | $4.2B | |
| Revenue (Reported) | $4.6B | $5B | $5.3B | $6B | $6.4B | |
| Operating Income (Reported) | $2.5B | $3B | $3.2B | $3.8B | $4.2B | |
| Operating Income (Adjusted) | $2.5B | $3B | $3.2B | $3.8B | $4.2B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $3.5B | $3.8B | $4.1B | $4.6B | $4.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $733.6M | $757.1M | $777.2M | $813.7M | $833.5M | |
| Gross Profit | $2.8B | $3.1B | $3.4B | $3.8B | $4B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $685.8M | $438.2M | $694.8M | $580.6M | $423.5M | |
| Operating Expenses | $795.3M | $706.9M | $789.9M | $806.7M | $828.5M | |
| Operating Income | $2B | $2.3B | $2.6B | $3B | $3.2B | |
| Net Interest Expenses | $125M | $122.8M | $119.7M | $120.2M | $129.7M | |
| EBT. Incl. Unusual Items | $2.6B | $2.7B | $3.1B | $3.4B | $3.8B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $562.6M | $609.9M | $736M | $793.6M | $862.8M | |
| Net Income to Company | $2B | $2.1B | $2.4B | $2.7B | $2.9B | |
| Minority Interest in Earnings | $500K | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $2B | $2B | $2.4B | $2.6B | $2.9B | |
| Basic EPS (Cont. Ops) | $5.61 | $5.68 | $6.63 | $7.29 | $7.93 | |
| Diluted EPS (Cont. Ops) | $5.60 | $5.64 | $6.63 | $7.27 | $7.92 | |
| Weighted Average Basic Share | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B | |
| Weighted Average Diluted Share | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B | |
| EBITDA | $2.3B | $2.6B | $2.8B | $3.2B | $3.5B | |
| EBIT | $2B | $2.3B | $2.6B | $3B | $3.2B | |
| Revenue (Reported) | $3.5B | $3.8B | $4.1B | $4.6B | $4.9B | |
| Operating Income (Reported) | $2B | $2.3B | $2.6B | $3B | $3.2B | |
| Operating Income (Adjusted) | $2B | $2.3B | $2.6B | $3B | $3.2B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.7B | $3B | $2.8B | $3B | $3B | |
| Short Term Investments | $100.9M | $115M | $96M | $111.7M | $113.2M | |
| Accounts Receivable, Net | $461.3M | $434.5M | $483.2M | $535.6M | $573.1M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $302M | $423M | $524.9M | $1.1B | $553.1M | |
| Total Current Assets | $89.3B | $161.8B | $139.1B | $94.9B | $103B | |
| Property Plant And Equipment | $969.5M | $850.6M | $766.1M | $681.5M | $617.3M | |
| Long-Term Investments | $986.7M | $1B | $2.8B | $2.8B | $2.6B | |
| Goodwill | $10.8B | $10.5B | $10.5B | $10.5B | $10.5B | |
| Other Intangibles | $22B | $20.7B | $20.4B | $20.2B | $20B | |
| Other Long-Term Assets | $2B | $3.3B | $3.7B | $3.7B | $3.5B | |
| Total Assets | $124.7B | $197B | $174.3B | $129.8B | $137.6B | |
| Accounts Payable | $69.3M | $48.8M | $121.4M | $90.6M | $79.9M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | $749.8M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $88.1B | $159.6B | $137.6B | $93.3B | $101.5B | |
| Total Current Liabilities | $88.2B | $160.4B | $137.7B | $93.4B | $102.3B | |
| Long-Term Debt | $4B | $3.2B | $3.9B | $3.8B | $3B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $98.4B | $169.6B | $147.4B | $103.1B | $111.1B | |
| Common Stock | $3.6M | $3.6M | $3.6M | $3.6M | $3.6M | |
| Other Common Equity Adj | $134.9M | $53.5M | -$133.3M | -$55.6M | -$105.5M | |
| Common Equity | $26.3B | $27.4B | $26.9B | $26.7B | $26.5B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $31.6M | -- | -- | -- | -- | |
| Total Equity | $26.4B | $27.4B | $26.9B | $26.7B | $26.5B | |
| Total Liabilities and Equity | $124.7B | $197B | $174.3B | $129.8B | $137.6B | |
| Cash and Short Terms | $1.7B | $3B | $2.8B | $3B | $3B | |
| Total Debt | $4B | $3.2B | $3.9B | $3.8B | $3B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.6B | $2.2B | $2.4B | $2.4B | $2.6B | |
| Short Term Investments | $110.3M | $91.3M | $104.1M | $112.3M | -- | |
| Accounts Receivable, Net | $470.4M | $580.2M | $558.4M | $629.4M | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $357.9M | $471.8M | $616.9M | $615.5M | -- | |
| Total Current Assets | $151.6B | $143.3B | $90.8B | $103.1B | $152.8B | |
| Property Plant And Equipment | $878M | $787.5M | $699.8M | $627.8M | $575.1M | |
| Long-Term Investments | $2.8M | $200K | -- | -- | -- | |
| Goodwill | $10.5B | $10.4B | $10.5B | $10.5B | -- | |
| Other Intangibles | $20.8B | $20.5B | $20.3B | $20.1B | -- | |
| Other Long-Term Assets | $3.4B | $3.8B | $3.7B | $3.7B | -- | |
| Total Assets | $186.8B | $178.4B | $125.6B | $137.8B | $187.1B | |
| Accounts Payable | $71M | $95M | $53.8M | $129.9M | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | $14.5M | -- | $749.7M | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $149.6B | $140.5B | $87.8B | $99.9B | -- | |
| Total Current Liabilities | $150.4B | $140.6B | $87.9B | $100.8B | $149.6B | |
| Long-Term Debt | $3.2B | $3.9B | $3.8B | $3B | $3.7B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $159.5B | $150.2B | $97.4B | $109.6B | $159B | |
| Common Stock | $3.6M | $3.6M | $3.6M | $3.6M | $3.6M | |
| Other Common Equity Adj | $37.3M | -$99.8M | -$117.3M | -$10.9M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $27.3B | $28.3B | $28.2B | $28.2B | $28.2B | |
| Total Liabilities and Equity | $186.8B | $178.4B | $125.6B | $137.8B | $187.1B | |
| Cash and Short Terms | $1.6B | $2.2B | $2.4B | $2.4B | $2.6B | |
| Total Debt | $3.2B | $3.9B | $3.8B | $3B | $3.7B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.1B | $2.6B | $2.7B | $3.2B | $3.5B | |
| Depreciation & Amoritzation | $464.4M | $385.4M | $362.6M | $352.6M | $336.8M | |
| Stock-Based Compensation | $96M | $75.2M | $84.3M | $82.9M | $89.5M | |
| Change in Accounts Receivable | $28.2M | -$45.7M | -$51.1M | -$51.5M | -$39.4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.7B | $2.4B | $3.1B | $3.5B | $3.7B | |
| Capital Expenditures | $197.5M | $127.2M | $89.7M | $76.4M | $94M | |
| Cash Acquisitions | $5.5M | $4.5M | $3.1M | $2.4M | $3.6M | |
| Cash From Investing | -$175.5M | $58.4M | -$489.8M | $20.9M | -$82.6M | |
| Dividends Paid (Ex Special Dividend) | $2.1B | $2.2B | $2.6B | $3.2B | $3.6B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $741M | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$756.2M | -$16.4M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $49.7B | $71.1B | -$22.7B | -$45.1B | $8.7B | |
| Cash From Financing | -$2.5B | $69.9B | -$25.4B | -$48.3B | $5.1B | |
| Beginning Cash (CF) | $1.6B | $2.8B | $2.7B | $2.9B | $2.9B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $81.9M | $72.4B | -$22.8B | -$44.9B | $8.7B | |
| Ending Cash (CF) | $1.7B | $75.2B | -$20.1B | -$41.9B | $11.6B | |
| Levered Free Cash Flow | $2.5B | $2.3B | $3B | $3.4B | $3.6B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $926.3M | $679.6M | $750.2M | $912.8M | $908M | |
| Depreciation & Amoritzation | $96.2M | $90M | $88.3M | $83.9M | $82.6M | |
| Stock-Based Compensation | $15.6M | $19.4M | $18.9M | $20.3M | $24M | |
| Change in Accounts Receivable | $50.7M | $600K | $40.8M | -$29.7M | $25.5M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $631.6M | $657.8M | $856.7M | $1B | $968.1M | |
| Capital Expenditures | $31.7M | $24M | $19.9M | $29.8M | $18.4M | |
| Cash Acquisitions | -- | -$1.1M | -- | -- | -- | |
| Cash From Investing | $58.8M | -$23.6M | -$19.5M | -$29.5M | -$19.1M | |
| Dividends Paid (Ex Special Dividend) | $322.5M | $363.2M | $400M | $418.5M | $455.3M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | $8.2M | |
| Other Financing Activities | $7.9B | $1.5B | -$26.1B | $13.8B | -- | |
| Cash From Financing | -$342.1M | $1.2B | -$26.5B | $13.3B | $6.4B | |
| Beginning Cash (CF) | $1.5B | $2.1B | $2.3B | $2.3B | $2.5B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $348.3M | $1.8B | -$25.6B | $14.3B | $7.3B | |
| Ending Cash (CF) | $1.8B | $3.9B | -$23.3B | $16.6B | $9.8B | |
| Levered Free Cash Flow | $599.9M | $633.8M | $836.8M | $973.2M | $949.7M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.4B | $2.7B | $3B | $3.5B | $3.8B | |
| Depreciation & Amoritzation | $411.4M | $366.5M | $356.9M | $339.7M | $331.9M | |
| Stock-Based Compensation | $83.3M | $77.4M | $84.1M | $86.7M | $93M | |
| Change in Accounts Receivable | -$52.8M | -$111.3M | $21.4M | -$71.8M | -$14.1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.4B | $2.7B | $3.4B | $3.7B | $4.2B | |
| Capital Expenditures | $169.9M | $92.6M | $80M | $88.6M | $77.2M | |
| Cash Acquisitions | $1.5M | -- | -$406.9M | $2.4M | $3.6M | |
| Cash From Investing | -$61.3M | -$396.5M | $15.6M | -$77.7M | -$78.4M | |
| Dividends Paid (Ex Special Dividend) | $2.2B | $2.6B | $3.2B | $3.6B | $3.9B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $741M | -- | -- | -- | |
| Long-Term Debt Repaid | $304.6M | -$756.2M | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | $8.2M | |
| Other Financing Activities | $112.1B | -$9.2B | -$52.8B | $12.2B | -- | |
| Cash From Financing | -$2.2B | $51.5B | -$56B | $8.6B | $45.6B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $129.7M | $53.9B | -$52.6B | $12.3B | $49.7B | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $2.2B | $2.7B | $3.3B | $3.6B | $4.1B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2B | $2.1B | $2.4B | $2.7B | $2.9B | |
| Depreciation & Amoritzation | $290.9M | $272M | $266.3M | $253.4M | $248.5M | |
| Stock-Based Compensation | $56.6M | $58.8M | $58.6M | $62.4M | $65.9M | |
| Change in Accounts Receivable | -$81.8M | -$147.4M | -$74.9M | -$95.2M | -$69.9M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.7B | $2.1B | $2.4B | $2.7B | $3.1B | |
| Capital Expenditures | $99.9M | $65.3M | $55.6M | $67.8M | $51M | |
| Cash Acquisitions | $1.5M | -$1.1M | -- | -- | -- | |
| Cash From Investing | -$9.2M | -$464.1M | $41.3M | -$57.3M | -$53.1M | |
| Dividends Paid (Ex Special Dividend) | $1.9B | $2.3B | $2.8B | $3.2B | $3.5B | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $741M | -- | -- | $742.3M | |
| Long-Term Debt Repaid | -- | -$756.2M | -$16.4M | -- | -$750M | |
| Repurchase of Common Stock | -- | -- | -- | -- | $8.2M | |
| Other Financing Activities | $62.4B | -$18B | -$48.1B | $9.2B | $43.2B | |
| Cash From Financing | -$1.9B | -$20.3B | -$50.9B | $6.1B | $46.6B | |
| Beginning Cash (CF) | $3.5B | $6.1B | $5.8B | $5.6B | $5.9B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$171.5M | -$18.7B | -$48.5B | $8.7B | $49.7B | |
| Ending Cash (CF) | $3.3B | -$12.6B | -$42.7B | $14.2B | $55.6B | |
| Levered Free Cash Flow | $1.6B | $2B | $2.4B | $2.6B | $3.1B | |
Get CME Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CME
Sector
P/E ratio
26.79x
12.24x
PEG ratio
3.16x
0.31x
P/B ratio
3.54x
1.11x
Price / LTM sales
15.56x
1.85x
Growth Metrics
CME
Sector
Revenue growth
-2.95%
5.54%
Earnings growth
-0.64%
14.85%
Revenue (5-year growth)
4.67%
8.85%
Earnings forecast
$2.63
$0.62
Profitability
CME
Sector
Profitability FY 2024
$5B
--
Return on invested capital
12.02%
5.01%
Return on assets
2.35%
1.01%
Return on equity
13.68%
9.68%
Earnings Date
Last Earnings Date
Oct
22
Next Earnings Date
Feb
4
Estimated Next Earnings Date
Jan
21
Balance Sheet
CME
Sector
Total cash
$2.6B
$431.4M
Short term investments
$113.2M
$211.3M
Total assets
$137.6B
$3.1B
Long term debt
$3.7B
$79.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
